SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical representation of T cell recognizing and killing SARS-CoV-2 infected cell (top). Mutant SARS-CoV-2 is not pr

Updated on: April 22,2024

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesGraphical representation of T cell recognizing and killing SARS-CoV-2 infected cell (top). Mutant SARS-CoV-2 is not pr

Updated on:April 22,2024

Murray Valley encephalitis: Summer is over but mosquito-borne disease remains a risk in northern Australia

by Cameron Webb,The ConversationMosquitoes carry a variety of diseases. Credit: Cameron Webb, NSW Health PathologyCooler temperatures are fading our memories of summer and reducing numbers of mo

Updated on: April 30,2024

Murray Valley encephalitis: Summer is over but mosquito-borne disease remains a risk in northern Australia

by Cameron Webb,The ConversationMosquitoes carry a variety of diseases. Credit: Cameron Webb, NSW Health PathologyCooler temperatures are fading our memories of summer and reducing numbers of mo

Updated on:April 30,2024

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on: April 30,2024

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on:April 30,2024

Vaccine monitoring is crucial as SARS-CoV-2 variants continue to evolve, says study

by The Francis Crick InstituteCredit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCL

Updated on: March 20,2024

Vaccine monitoring is crucial as SARS-CoV-2 variants continue to evolve, says study

by The Francis Crick InstituteCredit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCL

Updated on:March 20,2024

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and

Updated on: October 01,2024

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and

Updated on:October 01,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on: April 10,2024

COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus

by Charité - Universitätsmedizin BerlinThe older a person with COVID-19 is, the higher the frequency of T-helper cells which react to the virus. However, fewer and fewer of these cells produce th

Updated on:April 10,2024

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on: March 20,2024

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on:March 20,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on: November 29,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on:November 29,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on: April 12,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on:April 12,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on: April 30,2024

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Updated on:April 30,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on: October 21,2024

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on:October 21,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on: April 22,2024

SARS-CoV-2: Alert immune system in the respiratory tract protects children from severe courses of the disease

by German Cancer Research CenterSynopsis SARS-CoV-2 infection is milder in children, but the underlying mechanisms are not fully understood. This study finds increased interactions between immune

Updated on:April 22,2024